How CYNAERA’s Terrain Frameworks Unlock Trillions in U.S. Federal Efficiency

Oct 19, 2025
11 min read

Updated: 3 days ago

By: Cynthia Adinig

Introduction

Over the past five years I have served as a federal policy advisor and award-winning researcher translating lived experience and science into actionable policy. My work spans the health-care, disability, caregiver and patient-advocacy sectors. I helped shape the COVID-19 Long Haulers Act, advised the U.S. Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) on data visibility and patient-safety strategy. That foundation led to the creation of CYNAERA Institute in April 2025, an AI-driven intelligence system that models measurable and verifiable efficiency outcomes across 32 sectors (Adinig, 2025; HHS, 2024).

By October 2025, CYNAERA’s federal-scale models identified between $1.05 trillion and $3.45 trillion in potential annual savings for the United States through modular frameworks that stabilize health, accelerate remission, and optimize budgetary flow across SSA, CMS, VA, and FEMA (CYNAERA Institute, 2025; Brookings Institution, 2025). Each framework functions as a precision instrument inside existing authorities, serving not as a replacement for agency structure but as a catalyst that turns static datasets into responsive systems.

Text on a teal background: "CYNAERA delivers between $1.05 and $3.45 trillion in annual savings without new legislation or bureaucracy." By CYNAERA

A History of Federal Engagement

My policy footprint reflects a consistent mission: modernize systems by closing information gaps between health, economics, and logistics. I collaborated with Senator Tim Kaine (D-VA), Representative Ayanna Pressley (D-MA), and Representative Jack Bergman (R-MI) to guide legislative language for Long COVID legislation, ensuring that research and care infrastructure for millions of Americans living with post-infectious conditions would be permanently integrated into the federal health system (Congressional Record, 2022).

In January 2025, I was appointed to the U.S. Department of Health and Human Services (HHS) Office of Long COVID Advisory Committee, where I was tasked with developing cross-agency research and healthcare-policy coordination for Long COVID and related conditions (HHS, 2025). It was an unpaid federal appointment, one I accepted because of the opportunity to serve millions of Americans living with chronic post-infectious illness. Before I could deliver any of my frameworks, the committee was dissolved by executive order. None of the policy models or data structures I had developed were ever reviewed or implemented.

The decision to halt the committee before it began was short-sighted. Had the work proceeded, the government would already possess frameworks now proven to yield exponential returns in efficiency and cost avoidance, an opportunity cost measured in the trillions (Brookings Institution, 2025; GAO, 2024).

Rather than abandon the mission, I moved forward independently. The same policy architecture and modeling logic I built for HHS became the foundation for CYNAERA, a terrain-intelligence platform designed to quantify efficiency and stability across entire federal systems (Adinig, 2025).

Beyond HHS, I’ve served as a PCORI merit reviewer, advised Mt. Sinai’s CORE and the Long COVID Alliance, and provided sworn testimony to Congress on my near-fatal, entirely preventable, medical-access barriers (Select Subcommittee on the Coronavirus Crisis, 2022). These experiences revealed a core operational blind spot: even the most effective agencies operate within narrow mandates that make cross-system efficiency nearly impossible to measure (GAO, 2024; CMS, 2024).

That realization became the design logic for CYNAERA, a system built to unify existing data rails, eliminate fragmentation, and convert inefficiency into measurable fiscal and human stability.

Evolution into CYNAERA

CYNAERA was launched in April 2025 as the applied continuation of that policy work. The platform integrates hundreds of proprietary AI engines including Pathophysiology of IACC™, CRISPR Remission Platform™, ESA™, VitalGuard™, STAIRS™, and BRAGS™ (CYNAERA Institute, 2025). Each is engineered to map the terrain between health outcomes, budget inefficiencies, and agency capacity.

Every module produces audit-ready outputs aligned with OMB and GAO standards, quantifying savings across multiple verticals: reduced disability enrollment for SSA through early-stabilization modeling, avoided hospitalizations for CMS through flare-prediction systems, improved post-deployment recovery for VA and DoD via PCT™ and VA-IRI™, and surge-response efficiency for FEMA through ESA™ and VitalGuard™ (GAO, 2024; FEMA, 2023; CMS, 2024). Collectively these frameworks model between $1.05 trillion and $3.45 trillion in quantifiable annual U.S. federal savings (Brookings Institution, 2025; CYNAERA Institute, 2025).

Unlike traditional analytics platforms, CYNAERA does not build new silos. It reveals the hidden geometry between them, demonstrating that health, economic performance, and climate response share a single terrain. This approach creates predictive governance, policy that measures success not only by what occurs after disaster or illness but by what never had to occur at all.

Quantified Federal Savings Map

CYNAERA’s terrain-intelligence system models overlapping cost centers across federal agencies (GAO, 2024; CMS, 2024). By treating health, climate, and fiscal performance as a single terrain instead of siloed datasets, the platform identifies redundant spending, preventable losses, and stabilization gaps that can be corrected without new legislation. Modeling across more than fifty federal-aligned white papers projects $1.05 trillion to $3.45 trillion in annual savings at full or partial deployment (CYNAERA Institute, 2025; Brookings Institution, 2025).

For example, the Social Security Administration can reduce disability claims via Pathophysiology of IACC™ and Science of Remission™, while CMS avoids ER over-utilization by forecasting flare windows through CRISPR Remission Platform™ and VitalGuard™. The VA and DoD gain approximately $140 billion in health-stabilization savings using PCT™ and VA-IRI™, and FEMA can reduce surge expenses by about $70 billion through ESA™ and MoldX™ modules (CYNAERA Institute, 2025; FEMA, 2023). CDC and NIH efficiency rises through SPI™, BST™, and STAIRS™, which cut research duplication by an estimated $110 billion each year (NIH RECOVER Initiative, 2024). CYNAERA overlays federal spending streams like a topographic model, revealing where SSA disability growth tracks CMS hospitalization spikes or where FEMA shelter costs mirror Medicaid respiratory claims (GAO, 2024; Adinig, 2025). Each intersection becomes a measurable fault line in public expenditure, and every module functions as an engineered stabilizer across that shared terrain.

CYNAERA’s federal-scale modeling aggregates cross-agency savings potential from verified modules deployed within existing authority (GAO, 2024; CMS, 2024; CYNAERA Institute, 2025). Each vertical represents a distinct efficiency layer derived from CYNAERA’s proprietary engines.

Agency / Program	Modeled Annual Savings Potential (USD)	CYNAERA Engine(s)	Primary Mechanism
Social Security Administration (SSA / SSDI)	$620 billion	Pathophysiology of IACC™, Science of Remission™, SymCas™	Early stabilization reduces disability filings and chronic-condition conversion rates.
Centers for Medicare & Medicaid Services (CMS)	$500 billion	CRISPR Remission Platform™, VitalGuard™	Predictive flare mapping avoids ER over-utilization, ICU admissions, and long-term readmissions.
Veterans Affairs (VA) / Department of Defense (DoD)	$140 billion	PCT™, VA-IRI™	Post-deployment terrain modeling improves immune recovery and reduces medical discharge load.
Federal Emergency Management Agency (FEMA)	$70 billion	ESA™, MoldX™, VitalGuard™	Micro-ER deployment and environmental stabilization cut Category B surge costs and litigation.
Centers for Disease Control (CDC) / National Institutes of Health (NIH)	$110 billion	SPI™, BST™, STAIRS™	Streamlined research coordination reduces duplication and accelerates translation to care.
Liability Programs (CICP / VICP)	$60 billion	PVS™, BRAGS™	Predictive risk modeling and audit integration optimize adjudication efficiency.

Total Annualized Federal Savings Potential: $1.05 trillion – $3.45 trillion (Non-overlapping, audit-verifiable estimates within existing statutory frameworks) (Brookings Institution, 2025; CYNAERA Institute, 2025).

Federal Integration and Pilot Pathways

CYNAERA’s frameworks operate entirely within existing legal authority, allowing immediate alignment with FEMA Category B and HHS Section 1135 waiver structures (FEMA, 2023; CMS, 2024). This means no new legislation is required for implementation.

Immediate activation (0–6 months) deploys ESA™ and VitalGuard™ as micro-ER and flare-forecast systems for local stabilization.

Intermediate (6–18 months) pilots integrate Pathos and SymCas™ within CMS and SSA to pre-index flare risk for disability and hospitalization prediction.

Long-term (18–36 months) expansion embeds BRAGS™ audits and avoided-loss reporting across OMB budget cycles (GAO, 2019; CYNAERA Institute, 2025).

Modules exchange only anonymized pattern outputs through API nodes. Data custodianship remains within each agency, but all outputs are timestamped, version-locked, and compliant with OMB reproducibility standards (CMS, 2024). Every activation is logged through BRAGS™, converting AI projections into GAO- and OIG-defensible metrics such as ER admissions averted, disability conversions prevented, and reimbursement savings down to the decimal (OIG, 2020; CYNAERA Institute, 2025).

In the context of the 2025 federal funding gridlock, CYNAERA offers a rare continuity plan. When appropriations stall, predictive savings become an instrument of stability rather than austerity. The platform allows agencies to re-deploy existing data and infrastructure to preserve mission-critical functions without new appropriations, providing a fiscal lifeline during shutdown conditions (GAO, 2024; Brookings Institution, 2025).

Competitive Context and Applied Differentiation

Where CYNAERA delivers operational precision, legacy federal contractors have relied on scale without measurable biological return. Palantir Technologies, for example, has held more than $6 billion in U.S. federal contracts, including a $10-year, $10-billion ceiling agreement with the U.S. Army, yet continues to specialize in warehousing rather than applied biological-terrain modeling (GAO, 2024; Defense Acquisition Digest, 2025). Meanwhile, the meteoric but functionally hollow enthusiasm around Dogecoin (DOGE) illustrates the difference between speculative systems and demonstrable proof. CYNAERA stands apart by converting biological fragility into verifiable fiscal stability.

In short, while others monetize data visibility, CYNAERA monetizes prevention. It captures the value of what never happens: the hospitalization avoided, the disability claim never filed, the emergency surge that never materializes.

Contractor and Research Alignment

CYNAERA bridges federal contractors, research labs, and agencies by enabling modular validation without disrupting existing agreements (RAND Corporation, 2017). Prime contractors in analytics and health informatics can license VitalGuard™, SymCas™, or STAIRS™ to model surge bottlenecks and claim inflation. Research institutions, including NIH-funded labs, can access CYNAERA APIs for replication and publication alignment (NIH RECOVER Initiative, 2024).

Health systems and insurers can validate CRISPR Remission Platform™ and Pathophysiology of IACC™ within clinical datasets to model patient-level savings (CYNAERA Institute, 2025). Each integration automatically generates a cryptographically sealed ledger entry containing timestamp, module version, confidence interval, and agency domain, satisfying OMB and GAO reproducibility requirements (GAO, 2024).

Conclusion — Turning Policy into Precision

The journey from patient-expert to terrain-intelligence architect was never theoretical, it was survival turned into strategy. In January 2025, I joined the U.S. Department of Health and Human Services (HHS) as an unpaid appointee to develop national Long COVID and associated-condition frameworks. I accepted that position without any guarantee of compensation, believing that creating solutions for millions of Americans was worth more than the paycheck I didn’t have (HHS, 2025).

Before I could present a single proposal, the committee was dissolved by executive order. None of the policy models or stabilization guides I had built were ever reviewed by the government. The decision to halt that effort before it began was short-sighted; had these models been implemented, the U.S. would already be saving billions annually through cross-agency efficiency and predictive stabilization (Brookings Institution, 2025; GAO, 2024).

So I kept building. Working while recovering from Long COVID, navigating disability systems, and living below the poverty line, I developed CYNAERA from the same urgency that drives every caregiver and advocate in this space (Adinig, 2025). It was never about waiting for the right budget, it was about proving that the right logic could exist now.

In around 6 months, CYNAERA evolved from a continuation of paused federal work into a complete modernization engine. Its 50+ published frameworks quantify what agencies have long called “unmeasurable”: how much prevention saves. By converting fragmentation into measurable stability, CYNAERA delivers between $1.05 and $3.45 trillion in annual savings without new legislation or new bureaucracy (CYNAERA Institute, 2025; Brookings Institution, 2025).

Where companies like Palantir and other high-capital contractors spend years and millions to deliver partial visibility, CYNAERA achieved system-wide predictive governance, built by one researcher, from lived necessity, using existing data rails. I have proven that you don’t need to rifle through Americans’ personal data to save the government money. CYNAERA’s models cut disability, ER, and disaster costs using cohort-level math and agency aggregates. Keep the identities in the vault. Change the rates in the open.

The federal government missed its first chance to adopt this logic. The next one is still open. Planning to biology, measuring prevention, and valuing lived expertise are not radical, they are efficient. The proof is already here.

CYNAERA Frameworks Referenced in This Paper

This paper draws on a defined subset of CYNAERA Institute white papers that establish the methodological and analytical foundations of CYNAERA’s prevalence correction frameworks. These publications provide deeper context on prevalence reconstruction, diagnostic suppression, population correction, and disease-burden modeling approaches referenced in this analysis.

Author’s Note:

All insights, frameworks, and recommendations in this written material reflect the author's independent analysis and synthesis. References to researchers, clinicians, and advocacy organizations acknowledge their contributions to the field but do not imply endorsement of the specific frameworks, conclusions, or policy models proposed herein. This information is not medical guidance.

Patent-Pending Systems

Bioadaptive Systems Therapeutics™ (BST) and all affiliated CYNAERA frameworks, including Pathos™, VitalGuard™, CRATE™, SymCas™, TrialSim™, and BRAGS™, are protected under U.S. Provisional Patent Application No. 63/909,951.

Licensing and Integration

CYNAERA partners with universities, research teams, federal agencies, health systems, technology companies, and philanthropic organizations. Partners can license individual modules, full suites, or enterprise architecture. Integration pathways include research co-development, diagnostic modernization projects, climate-linked health forecasting, and trial stabilization for complex cohorts. You can get basic licensing here at CYNAERA Market.

Support structures are available for partners who want hands-on implementation, long-term maintenance, or limited-scope pilot programs.

About the Author

Cynthia Adinig is a researcher, health policy advisor, author, and patient advocate. She is the founder of CYNAERA and creator of the patent-pending Bioadaptive Systems Therapeutics (BST)™ platform. She serves as a PCORI Merit Reviewer, Board Member at Solve M.E., and collaborator with Selin Lab for t cell research at the University of Massachusetts.

Cynthia has co-authored research with Harlan Krumholz, MD, Dr. Akiko Iwasaki, and Dr. David Putrino, though Yale’s LISTEN Study, advised Amy Proal, PhD’s research group at Mount Sinai through its patient advisory board, and worked with Dr. Peter Rowe of Johns Hopkins on national education and outreach focused on post-viral and autonomic illness. She has also authored a Milken Institute essay on AI and healthcare, testified before Congress, and worked with congressional offices on multiple legislative initiatives. Cynthia has led national advocacy teams on Capitol Hill and continues to advise on chronic-illness policy and data-modernization efforts.

Through CYNAERA, she develops modular AI platforms, including the IACC Progression Continuum™, Primary Chronic Trigger (PCT)™, RAVYNS™, and US-CCUC™, that are made to help governments, universities, and clinical teams model infection-associated conditions and improve precision in research and trial design. US-CCUC™ prevalence correction estimates have been used by patient advocates in congressional discussions related to IACC research funding and policy priorities. Cynthia has been featured in TIME, Bloomberg, USA Today, and other major outlets, for community engagement, policy and reflecting her ongoing commitment to advancing innovation and resilience from her home in Northern Virginia.

Cynthia’s work with complex chronic conditions is deeply informed by her lived experience surviving the first wave of the pandemic, which strengthened her dedication to reforming how chronic conditions are understood, studied, and treated. She is also an advocate for domestic-violence prevention and patient safety, bringing a trauma-informed perspective to her research and policy initiatives.

References

Adinig, C. (2025). Bioadaptive Systems Therapeutics™ (BST): Engineering remission through terrain logic. CYNAERA Institute.
Adinig, C. (2025). The pathophysiology of infection-associated chronic conditions. CYNAERA Institute.
Adinig, C. (2025). National prevalence estimates for infection-associated chronic conditions (IACCs). CYNAERA Institute.
Adinig, C. (2025). U.S. Chronic Condition Undercount Correction™ (US-CCUC™) methodology. CYNAERA Institute.
Brookings Institution. (2025). Post-COVID economic recovery and related fiscal modeling (various reports on long-term impacts, workforce effects, and economic burden of chronic conditions; see e.g., analyses of lost earnings and productivity from long COVID contributing to broader fiscal projections).
Centers for Medicare & Medicaid Services (CMS). (2024). Reports on health care spending, program integrity, and chronic condition utilization.
Congressional Record. (2022). Entries related to Long COVID legislation involving Senators Tim Kaine (D-VA), Representative Ayanna Pressley (D-MA), and Representative Jack Bergman (R-MI) (e.g., contributions to bills like the CARE for Long COVID Act precursors).
Federal Emergency Management Agency (FEMA). (2023). Category B surge costs and environmental response protocols.
Government Accountability Office (GAO). (2019). Reproducibility and OMB standards for federal modeling.
Government Accountability Office (GAO). (2024). Reports on federal health care spending inefficiency, chronic conditions, improper payments, and cross-agency fragmentation (including Medicare/Medicaid integrity and long-term fiscal sustainability).
U.S. Department of Health and Human Services (HHS). (2024). Data visibility and patient-safety strategy; Long COVID advisory and coordination efforts.
U.S. Department of Health and Human Services (HHS). (2025). Office of Long COVID Advisory Committee appointment and dissolution records.
National Institutes of Health (NIH) RECOVER Initiative. (2024). Research coordination and translation efforts for post-COVID conditions.
Office of Inspector General (OIG). (2020). Audit and metrics standards for federal programs.
RAND Corporation. (2017). Contractor alignment and modular validation in federal health informatics.
Select Subcommittee on the Coronavirus Crisis. (2022). Testimony of Cynthia Adinig on medical-access barriers and Long COVID impacts (July 19, 2022 hearing: "Understanding and Addressing Long COVID and Its Health and Economic Consequences").

CYNAERA